BMRN Earnings

Quarterly EPS
$0.56
Q3 2024
$0.66
Q4 2024
$0.97
Q1 2025
$1.25
Q2 2025
$-0.16
Q3 2025
$-0.24
Q4 2025
$0.55
Q1 2026
$0.23
Q2 2026
Latest Revenue989.7M
Latest Net Income44.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.23989.7M44.8M+19.9%-81.6%
Q1 2026$0.55766.2M105.5M+2.8%-43.3%
Q4 2025-$0.24874.6M-46573000+17.0%-136.4%
Q3 2025-$0.16776.1M-30744000+4.1%-128.6%
Q2 2025$1.25825.4M240.5M+15.9%+123.2%
Q1 2025$0.97745.1M185.7M+14.8%+106.4%
Q4 2024$0.66747.3M124.9M+15.6%+500.0%
Q3 2024$0.56745.7M106.1M+28.3%+166.7%
Q2 2024$0.56712.0M107.2M
Q1 2024$0.47648.8M88.7M
Q4 2023$0.11646.2M20.4M
Q3 2023$0.21581.3M40.4M
BioMarin Pharmaceuticals (BMRN) — Earnings